<DOC>
	<DOCNO>NCT01930565</DOCNO>
	<brief_summary>In 8 week double blind randomize control split-face study , try compare clinical efficacy , safety histopathological change Lactobacillus ferment Chamaecypris obtusa ( LFCO ) exist tea tree oil ( TTO ) Basically , split face study - one side face randomly assign applied LFCO side TTO patient .</brief_summary>
	<brief_title>Effectiveness Safety New Botanical Component-LFCO- Compared With Existing TTO Clinical Study</brief_title>
	<detailed_description>Screening natural compound development anti-acne therapeutic agent steadily require consider various side effect acne medications.However , previous study mainly focus experimental test without clinical trial histopathological analysis . To compare clinical efficacy , safety histopathological change Lactobacillus ferment Chamaecypris obtusa ( LFCO ) exist tea tree oil ( TTO ) Total thirty four patient instruct apply 5 % LFCO involve area randomly allocate side 5 % TTO extract side 8 week double blind split-face clinical trial .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Tea Tree Oil</mesh_term>
	<criteria>age 1945 active acne lesion side face available study period pregnancy , mental illness , intake oral isotretinoin within 6 month , application oral topical acne medication , chemical peel light base treatment within 6 week .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>acne</keyword>
	<keyword>therapeutic</keyword>
	<keyword>clinical trial</keyword>
	<keyword>natural compound</keyword>
	<keyword>Lactobacillus ferment Chamaecypris obtuse</keyword>
	<keyword>tea tree oil</keyword>
</DOC>